SHAUNA GARDNER

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act.

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B drug pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Center for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-based purchasing/payments; Post-acute and home health care payments; Drug pricing and Medicare Parts B and D; Medicare regulatory reform; Oppose site neutral cuts and 340B cuts; Medicaid funding; Health care innovation; Digital health; Regulatory relief/waivers; S. 433 Home Health Payment Innovation Act of 2019; S. 296 Home Health Care Planning Improvement Act of 2019; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act, Surprise Billing.

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

340B drug pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Center for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-based purchasing/payments; Post-acute and home health care payments; Drug pricing and Medicare Parts B and D; Medicare regulatory reform; Oppose site neutral cuts and 340B cuts; Medicaid funding; Health care innovation; Digital health; Regulatory relief/waivers; S. 433 Home Health Payment Innovation Act of 2019; S. 296 Home Health Care Planning Improvement Act of 2019; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act, Surprise Billing.

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act.

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B drug pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Center for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-based purchasing/payments; Post-acute and home health care payments; Drug pricing and Medicare Parts B and D; Medicare regulatory reform; Oppose site neutral cuts and 340B cuts; Medicaid funding; Health care innovation; Digital health; Regulatory relief/waivers; S. 433 Home Health Payment Innovation Act of 2019; S. 296 Home Health Care Planning Improvement Act of 2019; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act, Surprise Billing.

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B drug pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Center for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-based purchasing/payments; Post-acute and home health care payments; Drug pricing and Medicare Parts B and D; Medicare regulatory reform; Oppose site neutral cuts and 340B cuts; Medicaid funding; Health care innovation; Digital health; Regulatory relief/waivers; S. 433 Home Health Payment Innovation Act of 2019; S. 296 Home Health Care Planning Improvement Act of 2019; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act, Surprise Billing.

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B drug pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Center for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-based purchasing/payments; Post-acute and home health care payments; Drug pricing and Medicare Parts B and D; Medicare regulatory reform; Oppose site neutral cuts and 340B cuts; Medicaid funding; Antikickback reform; Health care innovation; Digital health; Regulatory relief/waivers; S. 433 Home Health Payment Innovation Act of 2019; S. 296 Home Health Care Planning Improvement Act of 2019.

340B drug pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Center for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-based purchasing/payments; Post-acute and home health care payments; Drug pricing and Medicare Parts B and D; Medicare regulatory reform; Oppose site neutral cuts and 340B cuts; Medicaid funding; Health care innovation; Digital health; Regulatory relief/waivers; S. 433 Home Health Payment Innovation Act of 2019; S. 296 Home Health Care Planning Improvement Act of 2019; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act, Surprise Billing.

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B drug pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Center for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-based purchasing/payments; Post-acute and home health care payments; Drug pricing and Medicare Parts B and D; Medicare regulatory reform; Oppose site neutral cuts and 340B cuts; Medicaid funding; Health care innovation; Digital health; Regulatory relief/waivers; S. 433 Home Health Payment Innovation Act of 2019; S. 296 Home Health Care Planning Improvement Act of 2019; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act, Surprise Billing.

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B drug pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Center for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-based purchasing/payments; Post-acute and home health care payments; Drug pricing and Medicare Parts B and D; Medicare regulatory reform; Oppose site neutral cuts and 340B cuts; Medicaid funding; Antikickback reform; Health care innovation; Digital health; Regulatory relief/waivers; S. 433 Home Health Payment Innovation Act of 2019; S. 296 Home Health Care Planning Improvement Act of 2019.

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

340B drug pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Center for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-based purchasing/payments; Post-acute and home health care payments; Drug pricing and Medicare Parts B and D; Medicare regulatory reform; Oppose site neutral cuts and 340B cuts; Medicaid funding; Health care innovation; Digital health; Regulatory relief/waivers; S. 433 Home Health Payment Innovation Act of 2019; S. 296 Home Health Care Planning Improvement Act of 2019; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act, Surprise Billing.

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

340B drug pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Center for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-based purchasing/payments; Post-acute and home health care payments; Drug pricing and Medicare Parts B and D; Medicare regulatory reform; Oppose site neutral cuts and 340B cuts; Medicaid funding; Health care innovation; Digital health; Regulatory relief/waivers; S. 433 Home Health Payment Innovation Act of 2019; S. 296 Home Health Care Planning Improvement Act of 2019; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act, Surprise Billing.

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

340B Program; Medicare Three Day Stay Rule; Medicare Shared Savings Program; Medicaid Provider Tax; Medicare Conditions of Participation; Home Health; Medicare Advantage; Graduate Medical Education; Center for Medicare and Medicaid Innovation; Bundled Payment for Care Improvement - Advanced Model; IMPACT Act Implementation; HR 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B discount drug program shall have no force or effect, and for other purposes; Stark Law Reform/Modernization; Value based-purchasing/payments; HR 2118 Medical Device Servicing Safety Accountability Act; Inpatient prospective payment system rule; CHIP rescission cuts.

340B Program; Medicare Three Day Stay Rule; Medicare Shared Savings Program; Medicare Conditions of Participation; 2019 Home Health Rule; Medicare Advantage; Graduate Medical Education; Center for Medicare and Medicaid Innovation; IMPACT Act implementation; HR 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes; Stark Law Reform/Modernization; Value-based purchasing/payments; HR 2118 Medical Device Servicing Safety and Accountability Act; Inpatient prospective payment system rule; Post acute care payment; Drug pricing; Medicare regulatory reform; Oppose OPPS site neutral cuts; MSSP digital signature change; MACRA; 2019 Physician fee schedule; 2019 OPPS Rule; Medicaid funding; Anti-kickback reform.

340B Program; Medicare Shared Savings Program; 2019 Home Health Rule; Medicare Advantage; Graduate Medical Education; Center for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-based purchasing/payments; H.R. 2118 Medical Device Servicing and Safety Accountability Act; Post acute care payment; Drug pricing; Medicare regulatory reform; Oppose site neutral cuts and 340B cuts in OPPS rule; 2019 OPPS Rule; Medicaid funding; Anti-kickback reform; Healthcare innovation; Digital health; Regulatory relief/waivers.

340B Program; CHIP Reauthorization; Medicare Three Day Stay Rule; Medicare Shared Savings Program; PAMA Implementation; Medicaid Provider Tax; Medicare Condition and Participation; Home Health; Medicare Advantage; Graduate Medical Education; Center for Medicare and Medicaid Innovation; Bundled Payment for Care Improvement- Advanced Model; IMPACT Act Implementation; HR 4392, To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.

340B Program; Medicare Three Day Stay Rule; Medicare Shared Savings Program; Medicare Conditions of Participation; 2019 Home Health Rule; Medicare Advantage; Graduate Medical Education; Center for Medicare and Medicaid Innovation; IMPACT Act implementation; HR 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes; Stark Law Reform/Modernization; Value-based purchasing/payments; HR 2118 Medical Device Servicing Safety and Accountability Act; Inpatient prospective payment system rule; Post acute care payment; Drug pricing; Medicare regulatory reform; Oppose OPPS site neutral cuts; MSSP digital signature change; MACRA; 2019 Physician fee schedule; 2019 OPPS Rule; Medicaid funding; Anti-kickback reform.

340B Program; Medicare Three Day Stay Rule; Medicare Shared Savings Program; Medicaid Provider Tax; Medicare Conditions of Participation; Home Health; Medicare Advantage; Graduate Medical Education; Center for Medicare and Medicaid Innovation; Bundled Payment for Care Improvement - Advanced Model; IMPACT Act Implementation; HR 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B discount drug program shall have no force or effect, and for other purposes; Stark Law Reform/Modernization; Value based-purchasing/payments; HR 2118 Medical Device Servicing Safety Accountability Act; Inpatient prospective payment system rule; CHIP rescission cuts.

Tax Code and Reform; HR 1 The Tax Cuts and Jobs Act provisions related to taxation and bonds, and charitable donations

Tax Code and Reform; HR 1 The Tax Cuts and Jobs Act provisions related to taxation and bonds, and charitable donations

Drug Pricing; Affordable Care Act (ACA) implementation; Health Care Reform Senate Bills; H.R. 1628 Better Care Reconciliation Act

Prescription drug costs and pricing; Medicare Access and CHIP reauthorization Act (MACRA) implementation; 340B Program; Medicaid/Federal Medical Assistance Percentages(FMAP); S. 428 ACE Kids Act of 2017; Medicaid Provisions in Senate Health Care Reform Bills; 2018 hospital Outpatient Prospective Payment System Rule; 2018 Home Health Payment Rule; CHIP Reauthorization; HR 1628 Better Care Reconciliation Act; Medicare Three Day Stay Rule; Medicare Shared Savings Program; Behavioral Health Issues in Medicaid Program; 2018 Medicare Quality Payment Program Rule

Drug Pricing; Affordable Care Act (ACA); Health Care Reform; Behavioral Health; H.R. 1628-the American Health Care Act; H.R. 2118 Medical Device Servicing Safety and Accountability Act; Opioid/ substance use disorder.

Drug Pricing; Affordable Care Act (ACA); Health Care Reform; Behavioral Health; H.R. 1628- the American Health Care Act.

Drug Pricing; Affordable Care Act (ACA); Health Care Reform; Behavioral Health; H.R. 1628-the American Health Care Act; H.R. 2118 Medical Device Servicing Safety and Accountability Act; Opioid/ substance use disorder.

Prescription drug costs and pricing; Medicare Access and CHIP reauthorization Act (MACRA) implementation; 340B Program; Medicaid/Federal Medical Assistance Percentages(FMAP); 2018 hospital Outpatient Prospective Payment System Rule; 2018 Home Health Payment Rule; CHIP Reauthorization; Medicare Three Day Stay Rule; Medicare Shared Savings Program; Behavioral Health Issues in Medicaid Program; 2018 Medicare Quality Payment Program Rule; PAMA Implementation; HR 4392, To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.

Prescription drug costs and pricing; Medicare Access and CHIP reauthorization Act (MACRA) implementation; 340B Program; Medicaid/Federal Medical Assistance Percentages(FMAP); S. 428 ACE Kids Act of 2017; Medicaid Provisions in Senate Health Care Reform Bills; 2018 hospital Outpatient Prospective Payment System Rule; 2018 Home Health Payment Rule; CHIP Reauthorization; HR 1628 Better Care Reconciliation Act; Medicare Three Day Stay Rule; Medicare Shared Savings Program; Behavioral Health Issues in Medicaid Program; 2018 Medicare Quality Payment Program Rule

IMPACT Act implementation; Prescription drug costs and pricing; Medicare Access and CHIP reauthorization Act (MACRA) implementation; home health pre-claim review demonstration; 340B Program; Medicaid/Federal Medical Assistance Percentages(FMAP); S. 428 ACE Kids Act of 2017

IMPACT Act implementation; Accountable Care Organizations/Medicare Shared Savings Program; Pay for Value/Delivery System Reform; Post-acute care/skilled nursing facilities access; Home Health Care payment rates; Prescription drug costs and pricing; Alternative Payment models including bundling; Medicare Access and CHIP reauthorization Act (MACRA) implementation; Center for Medicare and Medicaid Services Technical Expert Panel nominations; home health pre-claim review demonstration; Section 1115 Waivers; H.R. 3298 the Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R. 6043 Fair Drug Pricing Act of 2015; Protecting Access to Medicare Act Implementation.

IMPACT Act implementation; Accountable Care Organizations/Medicare Shared Savings Program; Pay for Value/Delivery System Reform; S. 298/H.R. 546 - ACE Kids Act of 2015; Site neutral payments; Post-acute care/skilled nursing facilities access; Home Health Care payment rates; Medicare Advantage Program; 340B Program; Prescription drug costs and pricing; Alternative Payment models including bundling; Medicare Access and CHIP reauthorization Act (MACRA) implementation; Center for Medicare and Medicaid Services Technical Expert Panel nominations; Medicare Evidence and Coverage Committee nominations; home health pre-claim review demonstration.

Graduate Medical Education Payment Issues; Accountable Care Organizations/Medicare Shared Savings Program; Pay for Value/Delivery System Reform; S. 298/H.R. 546 - ACE Kids Act of 2015; Site neutral payments; Post-acute care/skilled nursing facilities access; Home Health Care payment rates; Medicare Advantage Program; 340B Program; Prescription drug costs and pricing; Alternative Payment models; Finance Committee healthcare working group effort; Medicare Access and CHIP reauthorization Act (MACRA) implementation.

Graduate Medical Education Payment Issues; Accountable Care Organizations/Medicare Shared Savings Program; Pay for Value/Delivery System Reform; S. 298/H.R. 546 - ACE Kids Act of 2015; Site neutral payments; Post-acute care/skilled nursing facilities access; Home Health Care payment rates; Medicare Advantage Program; 340B Program; Prescription drug costs and pricing; Alternative Payment models; Medicare Access and CHIP reauthorization Act (MACRA) implementation; Medicare Star Ratings System Delay; PAMA Implementation

IMPACT Act implementation; Accountable Care Organizations/Medicare Shared Savings Program; Pay for Value/Delivery System Reform; Post-acute care/skilled nursing facilities access; Home Health Care payment rates; Prescription drug costs and pricing; Alternative Payment models including bundling; Medicare Access and CHIP reauthorization Act (MACRA) implementation; Center for Medicare and Medicaid Services Technical Expert Panel nominations; home health pre-claim review demonstration; Section 1115 Waivers; H.R. 3298 the Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R. 6043 Fair Drug Pricing Act of 2015; Protecting Access to Medicare Act Implementation.

IMPACT Act implementation; Accountable Care Organizations/Medicare Shared Savings Program; Pay for Value/Delivery System Reform; S. 298/H.R. 546 - ACE Kids Act of 2015; Site neutral payments; Post-acute care/skilled nursing facilities access; Home Health Care payment rates; Medicare Advantage Program; 340B Program; Prescription drug costs and pricing; Alternative Payment models including bundling; Medicare Access and CHIP reauthorization Act (MACRA) implementation; Center for Medicare and Medicaid Services Technical Expert Panel nominations; Medicare Evidence and Coverage Committee nominations; home health pre-claim review demonstration.

Graduate Medical Education Payment Issues; Accountable Care Organizations/Medicare Shared Savings Program; Pay for Value/Delivery System Reform; S. 298/H.R. 546 - ACE Kids Act of 2015; Site neutral payments; Post-acute care/skilled nursing facilities access; Home Health Care payment rates; Medicare Advantage Program; 340B Program; Prescription drug costs and pricing; Alternative Payment models; Finance Committee healthcare working group effort; Medicare Access and CHIP reauthorization Act (MACRA) implementation.

Graduate Medical Education Payment Issues; Accountable Care Organizations/Medicare Shared Savings Program; Pay for Value/Delivery System Reform; S. 298/H.R. 546 - ACE Kids Act of 2015; Site neutral payments; Post-acute care/skilled nursing facilities access; Home Health Care payment rates; Medicare Advantage Program; 340B Program; Prescription drug costs and pricing; Alternative Payment models; Medicare Access and CHIP reauthorization Act (MACRA) implementation; Medicare Star Ratings System Delay; PAMA Implementation

Graduate Medical Education Payment Issues; Implementation of the Patient Protection & Affordable Care Act (P.L. 111-148); Accountable Care Organizations/Medicare Shared Savings Program; Quality of Care Measurements/Pay for Value/Delivery System Reform; S. 298/H.R. 546 - ACE Kids Act of 2015; site neutral payments; post-acute care/skilled nursing facilities access; Medicare three-day rule, observation stays policies; Home Health Care payment rates; ICD 10 Implementation; Medicare Advantage Program; Postacute care/skilled nursing facility funding; two midnight and Medicare short stay policies; 340B Program; H.R. 2156 - Recovery Audit Contractor Program Reform; CHIP Reauthorization; SGR Reform (H.R. 2).

Graduate Medical Education Payment Issues; Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Accountable Care Organizations/Medicare Shared Savings Program; Quality of Care Measurements/Pay for Value/Delivery System Reform; H.R. 546 -ACE Kids Act of 2015; site neutral payments; post-acute care/skilled nursing facilities access; Medicare three-day rule, observation stays policies; Home Health Care payment rates; ICD 10 Implementation; Medicare Advance Program; Postacute care/skilled nursing facility funding; two midnight and Medicare short stay policies; 340B Program; Recovery Audit Contractor Program Reform; CHIP Reauthorization; Federal Medical Assistance Percentage Formula; Value Based Purchasing; SGR Reform (H.R. 2).

Graduate Medical Education Payment Issues; Accountable Care Organizations/Medicare Shared Savings Program; Pay for Value/Delivery System Reform; S. 298/H.R. 546 - ACE Kids Act of 2015; site neutral payments; post-acute care/skilled nursing facilities access; Medicare three-day rule, observation stays policies; Home Health Care payment rates; Medicare Advantage Program; Two midnight and Medicare short stay policies; 340B Program; H.R. 2156 - Medicare Audit Improvement Act of 2015; Prescription drug costs; Recovery Audit Contractor Program Reform; Alternative Payment models; Drug Pricing.

Graduate Medical Education Payment Issues; Implementation of the Patient Protection & Affordable Care Act (P.L. 111-148); Accountable Care Organizations/Medicare Shared Savings Program; Quality of Care Measurements/Pay for Value/Delivery System Reform; S. 298/H.R. 546 - ACE Kids Act of 2015; site neutral payments; post-acute care/skilled nursing facilities access; Medicare three-day rule, observation stays policies; Home Health Care payment rates; ICD 10 Implementation; Medicare Advantage Program; Postacute care/skilled nursing facility funding; two midnight and Medicare short stay policies; 340B Program; H.R. 2156 - Recovery Audit Contractor Program Reform; CHIP Reauthorization; SGR Reform (H.R. 2).

Graduate Medical Education Payment Issues; Accountable Care Organizations/Medicare Shared Savings Program; Quality of Care Measurements/Pay for Value/Delivery System Reform; S. 298/H.R. 546 - ACE Kids Act of 2015; site neutral payments; post-acute care/skilled nursing facilities access; Medicare three-day rule, observation stays policies; Home Health Care payment rates; ICD 10 Implementation; Medicare Advantage Program; Postacute care/skilled nursing facility funding; two midnight and Medicare short stay policies; 340B Program; H.R. 2156 - Medicare Audit Improvement Act of 2015; CHIP Reauthorization; Recovery Audit Contractor Program Reform; Alternative Payment models.

Graduate Medical Education Payment Issues; Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Accountable Care Organizations/Medicare Shared Savings Program; Quality of Care Measurements/Pay for Value/Delivery System Reform; H.R. 546 -ACE Kids Act of 2015; site neutral payments; post-acute care/skilled nursing facilities access; Medicare three-day rule, observation stays policies; Home Health Care payment rates; ICD 10 Implementation; Medicare Advance Program; Postacute care/skilled nursing facility funding; two midnight and Medicare short stay policies; 340B Program; Recovery Audit Contractor Program Reform; CHIP Reauthorization; Federal Medical Assistance Percentage Formula; Value Based Purchasing; SGR Reform (H.R. 2).

Graduate Medical Education Payment Issues; Implementation of the Patient Protection & Affordable Care Act (P.L. 111-148); Accountable Care Organizations/Medicare Shared Savings Program; Quality of Care Measurements/Pay for Value/Delivery System Reform; S. 298/H.R. 546 - ACE Kids Act of 2015; site neutral payments; post-acute care/skilled nursing facilities access; Medicare three-day rule, observation stays policies; Home Health Care payment rates; ICD 10 Implementation; Medicare Advantage Program; Postacute care/skilled nursing facility funding; two midnight and Medicare short stay policies; 340B Program; H.R. 2156 - Recovery Audit Contractor Program Reform; CHIP Reauthorization; SGR Reform (H.R. 2).

Graduate Medical Education Payment Issues; Accountable Care Organizations/Medicare Shared Savings Program; Quality of Care Measurements/Pay for Value/Delivery System Reform; S. 298/H.R. 546 - ACE Kids Act of 2015; site neutral payments; post-acute care/skilled nursing facilities access; Medicare three-day rule, observation stays policies; Home Health Care payment rates; ICD 10 Implementation; Medicare Advantage Program; Postacute care/skilled nursing facility funding; two midnight and Medicare short stay policies; 340B Program; H.R. 2156 - Medicare Audit Improvement Act of 2015; CHIP Reauthorization; Recovery Audit Contractor Program Reform; Alternative Payment models.

Graduate Medical Education Payment Issues; Accountable Care Organizations/Medicare Shared Savings Program; Pay for Value/Delivery System Reform; S. 298/H.R. 546 - ACE Kids Act of 2015; site neutral payments; post-acute care/skilled nursing facilities access; Medicare three-day rule, observation stays policies; Home Health Care payment rates; Medicare Advantage Program; Two midnight and Medicare short stay policies; 340B Program; H.R. 2156 - Medicare Audit Improvement Act of 2015; Prescription drug costs; Recovery Audit Contractor Program Reform; Alternative Payment models; Drug Pricing.